In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.
about
Azithromycin for treating uncomplicated malariaPlasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter.Pharmacokinetic properties of azithromycin in pregnancyGlobal Infectious Disease Surveillance at DoD Overseas Laboratories, 1999-2007In vitro selection of Plasmodium falciparum drug-resistant parasite lines.Preliminary pharmaceutical development of antimalarial-antibiotic cotherapy as a pre-referral paediatric treatment of fever in malaria endemic areas.Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replicationMirincamycin, an old candidate for malaria combination treatment and prophylaxis in the 21st century: in vitro interaction profiles with potential partner drugs in continuous culture and field isolatesModelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challengesIsoprenoid precursor biosynthesis is the essential metabolic role of the apicoplast during gametocytogenesis in Plasmodium falciparum.In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipinePharmacokinetics and ex vivo antimalarial activity of artesunate-azithromycin in healthy volunteersAzithromycin plus chloroquine: combination therapy for protection against malaria and sexually transmitted infections in pregnancy.Assessing anti-malarial drug effects ex vivo using the haemozoin detection assay.Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina FasoMultiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplastBead-based immunoassay allows sub-picogram detection of histidine-rich protein 2 from Plasmodium falciparum and estimates reliability of malaria rapid diagnostic testsAntimalarial activity of tigecycline, a novel glycylcycline antibiotic.Select pyrimidinones inhibit the propagation of the malarial parasite, Plasmodium falciparumIntermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling.Pharmaceutical development and optimization of azithromycin suppository for paediatric use.The SYBR Green I malaria drug sensitivity assay: performance in low parasitemia samples.A novel live-dead staining methodology to study malaria parasite viability.Reliability of antimalarial sensitivity tests depends on drug mechanisms of action.Investigations into the role of the Plasmodium falciparum SERCA (PfATP6) L263E mutation in artemisinin action and resistance.Interaction between rifampicin, amodiaquine and artemether in mice infected with chloroquine resistant Plasmodium berghei.Development of NIRS method for quality control of drug combination artesunate-azithromycin for the treatment of severe malaria.Antimalarial drug interactions of compounds isolated from Kigelia africana (Bignoniaceae) and their synergism with artemether, against the multidrug-resistant W2mef Plasmodium falciparum strain.Azithromycin reduces ocular infection during congenital transmission of toxoplasmosis in the Calomys callosus model.In vitro antimalarial activity of tigecycline against Plasmodium falciparum culture-adapted reference strains and clinical isolates from the Brazilian AmazonSimultaneous Determination of Artemether and Azithromycin in Suppositories by Reversed Phase HPLC
P2860
Q24234168-08ABA9CF-8B6B-4FE5-A578-9FFF6AEDA382Q33346695-875DE9D8-2149-45F5-ABA9-92FCD6232ABCQ33558917-6D0EF9E2-BEF1-4CB1-BF3E-BB74EEE9DC72Q33578799-E1C74B3B-D0BA-4254-941B-4E958D41958DQ33636206-798AB6AB-96F8-4417-B97E-508DE38DAE68Q33710687-B6C13A38-3B9A-438E-B257-864DD6EA5552Q33759041-AABF4C2B-52D8-4440-8D22-50C983B66D95Q33764169-0BB15B60-A96A-4AB9-9E3D-AAED0FC2B12FQ34953705-9F478B60-5D45-4AA8-9E66-C216A1FD5F78Q35031730-2E62C782-A5D5-4467-8F9E-1DA1DCA8274EQ35065754-138AB401-7027-47DD-B21E-9DD4F3A37677Q35191531-6CDADBE3-5EB9-4C36-97F1-A8243AE0251AQ35205935-08D3C2BD-E950-4FFE-A504-2A4D83B079F6Q35368698-6779B57F-7E7D-42DC-B991-53FC1569E34AQ35760573-8A66A997-1A61-4072-B043-65DC7DB3CA85Q36095096-ED639170-54FD-4782-84B4-2D1449566F2DQ36278746-B7EB661B-233A-4DCE-9841-9C99B076C965Q37333066-BFC6E11E-79E0-41C3-8A75-B3DD27920E1FQ37417039-B3D11CE1-1B7F-4BDF-B5CC-C8890F4B1156Q37863203-C02D08B8-B767-4314-AB33-201A30499428Q38752586-2B163B6D-8419-4082-A4B0-7B5B3385882FQ39124475-CD45AAF6-F6FC-48C2-B25D-39D987B73E3DQ39324798-D95681CE-3230-4713-95BE-1F852886AA43Q39341007-4AA9F224-882C-416D-9999-B78480514CA7Q40344256-E99A8E9A-4501-4081-9CA3-E5501768961EQ41827568-EED81AA3-0240-4AE0-8BB4-698B42728A33Q41920557-21AF61AA-3E8C-40ED-8241-40414ECC4CD4Q42101124-DF0263C9-2916-4B11-B871-35A5419FF7ABQ42728338-EF6EC47C-CD41-4AEF-8E9D-051A1F79B048Q43202341-927EB5DD-18E3-4696-A6EF-D967901724ECQ56763188-BB56E8EB-0457-49C3-A5CA-3D547DDC9509Q58249809-041C0D14-E581-4E97-B255-9594F95ECC3C
P2860
In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
In vitro antimalarial activity ...... elation with clinical outcome.
@ast
In vitro antimalarial activity ...... elation with clinical outcome.
@en
type
label
In vitro antimalarial activity ...... elation with clinical outcome.
@ast
In vitro antimalarial activity ...... elation with clinical outcome.
@en
prefLabel
In vitro antimalarial activity ...... elation with clinical outcome.
@ast
In vitro antimalarial activity ...... elation with clinical outcome.
@en
P2093
P2860
P921
P356
P1476
In vitro antimalarial activity ...... elation with clinical outcome.
@en
P2093
Charles Knirsch
Colin Ohrt
Harald Noedl
Krisada Jongsakul
Kritsanai Yingyuen
Mark Fukuda
Noppadon Tangpukdee
Robert Scott Miller
Sabaithip Sriwichai
Wattana Leowattana
P2860
P304
P356
10.1128/AAC.01023-06
P407
P577
2006-11-20T00:00:00Z